Cargando…
CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial
Multiple sclerosis is a multifactorial chronic inflammatory disease of the central nervous system that leads to demyelination and neuronal cell death, resulting in functional disability. Remyelination is the natural repair process of demyelination, but it is often incomplete or fails in multiple scl...
Autores principales: | Gudi, Viktoria, Grieb, Paweł, Linker, Ralf A., Skripuletz, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358672/ https://www.ncbi.nlm.nih.gov/pubmed/37449595 http://dx.doi.org/10.4103/1673-5374.373671 |
Ejemplares similares
-
Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination
por: Gudi, Viktoria, et al.
Publicado: (2021) -
The choline pathway as a strategy to promote central nervous system (CNS) remyelination
por: Skripuletz, Thomas, et al.
Publicado: (2015) -
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
por: Gudi, Viktoria, et al.
Publicado: (2014) -
Effect of cdp-choline on microcirculatory alterations during endotoxemia
por: Schmidt, K, et al.
Publicado: (2013) -
Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019)